Circulating miR-320b Contributes to CD4+ T-Cell Proliferation in Systemic Lupus Erythematosus via MAP3K1
Journal of Immunology Research · 2023
DOI: 10.1155/2023/6696967 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Journal of Immunology Research, 2023. Verfasst von Zutong Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, MAP Kinase Kinase Kinase 1, MicroRNAs. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Basic Research Program of China, National Natural Science Foundation of China, Joint Research Project of China.
Abstract (Originalsprache)
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by the production of autoantibodies and tissue inflammation. Mesenchymal stem cells (MSCs) have emerged as a promising candidate therapy for SLE owing to the immunomodulatory and regenerative properties. Circulating miRNAs are small, single-stranded noncoding RNAs in a variety of body fluids that regulate numerous immunologic and inflammatory pathways. Recent studies have revealed many differentially expressed circulating miRNAs in autoimmune diseases including SLE. However, the role of circulating miRNAs in SLE has not been extensively studied. Here, we performed small RNA sequencing analysis to compare the circulating miRNA profiles of SLE patients before and after MSC transplantation (MSCT), and identified a significant decrease of circulating miR-320b level during MSCT. Importantly, we found that the expression of circulating miR-320b and its target gene MAP3K1 was closely associated with SLE disease activity. The in vitro experiments showed that decreased MAP3K1 level in SLE peripheral blood mononuclear cells (PBMCs) was involved in CD4+ T-cell proliferation. In MRL/lpr mice, miR-320b overexpression aggravated symptoms of SLE, while miR-320b inhibition could promote disease remission. Besides, MSCs regulate miR-320b/MAP3K1 expression both in vitro and in vivo. Our results suggested that circulating miR-320b and MAP3K1 may be involved in CD4+ T-cell proliferation in SLE. This trial is registered with NCT01741857.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
- Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, China.
- MOE Key Laboratory of Model Animals for Disease Study, Model Animal Research Center, Medical School of Nanjing University, Nanjing, China.
- Department of Rheumatology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.
ORCID-Profile: Zutong Li, Hua Song, Shuai Ding, Shanshan Liu, Lingyun Sun
Förderung
- National Basic Research Program of China
- National Natural Science Foundation of China
- Joint Research Project of China
Zitieren
APA
Li, Z., Wang, R., Wang, D., Zhang, S., Song, H., Ding, S., Zhu, Y., Wen, X., Li, H., Chen, H., Liu, S., & Sun, L. (2023). Circulating miR-320b Contributes to CD4+ T-Cell Proliferation in Systemic Lupus Erythematosus via MAP3K1. Journal of Immunology Research. https://doi.org/10.1155/2023/6696967
Vancouver
Li Z, Wang R, Wang D, Zhang S, Song H, Ding S, et al. Circulating miR-320b Contributes to CD4+ T-Cell Proliferation in Systemic Lupus Erythematosus via MAP3K1. Journal of Immunology Research. 2023. doi:10.1155/2023/6696967
BibTeX
@article{Li2023,
author = {Li, Zutong and Wang, Rou and Wang, Dandan and Zhang, Shujie and Song, Hua and Ding, Shuai and Zhu, Yantong and Wen, Xin and Li, Hui and Chen, Hongwei and Liu, Shanshan and Sun, Lingyun},
title = {Circulating miR-320b Contributes to CD4+ T-Cell Proliferation in Systemic Lupus Erythematosus via MAP3K1},
journal = {Journal of Immunology Research},
year = {2023},
doi = {10.1155/2023/6696967}
}
EUVIMED